Form 4: Director Nicholas Augustinos Receives DexCom RSU Grant

DexCom, Inc. director Nicholas Augustinos was granted 5,575 restricted stock units as part of his equity compensation.

Summary

• Director Nicholas Augustinos acquired 5,575 restricted stock units (RSUs) of DexCom, Inc. common stock.
• The grant was issued on May 28, 2026, at a price of $0 per share.
• The RSUs are scheduled to vest fully on the earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting of Stockholders.
• Following this transaction, the director holds 5,575 shares directly and 38,457 shares indirectly through a revocable trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• The grant aligns the director's long-term interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The RSUs will vest on the earlier of May 28, 2027, or the date of the 2027 Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that this is a routine equity compensation disclosure for a corporate director, which is standard practice for publicly traded companies to ensure board alignment with shareholder value.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is a standard governance practice among S&P 500 and NASDAQ-listed healthcare technology companies.
• The vesting schedule of one year or the next annual meeting is consistent with typical director compensation policies.

Related Party Transactions

• The reporting person maintains indirect ownership of 38,457 shares through the Kirschner/Augustinos Revocable Trust.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity grant to a director.

Next Steps

• Vesting of the RSU award on the earlier of May 28, 2027, or the 2027 Annual Meeting of Stockholders.

Key Dates

Keywords

DexCom, DXCM, Form 4, Insider Trading, Equity Compensation, Director